FDA takes 931 days to review brain cancer drug

Northwest Biotherapeutics submitted its brain cancer treatment for regulatory approval over 2.5 years ago, and it's still stuck in FDA limbo. This case highlights extreme delays in the drug approval process, especially for therapies for serious conditions.